130 related articles for article (PubMed ID: 22044610)
1. D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma.
Morii T; Mochizuki K; Tajima T; Ichimura S; Satomi K
BMC Musculoskelet Disord; 2011 Nov; 12():250. PubMed ID: 22044610
[TBL] [Abstract][Full Text] [Related]
2. D-dimer Level Changes During Systemic Chemotherapy Can Predict Prognosis of High-grade Musculoskeletal Sarcoma Patients.
Morii T; Tajima T; Aoyagi T; Ichimura S
Anticancer Res; 2015 Dec; 35(12):6781-6. PubMed ID: 26637896
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Raj SD; Zhou X; Bueso-Ramos CE; Ravi V; Patel S; Benjamin RS; Vadhan-Raj S
Am J Clin Oncol; 2012 Oct; 35(5):462-7. PubMed ID: 21654313
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients.
Xu K; Lou Y; Sun R; Liu Y; Li B; Li J; Huang Q; Wan W; Xiao J
World Neurosurg; 2019 Jan; 121():e104-e112. PubMed ID: 30218803
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.
Nakamura T; Katagiri H; Shido Y; Hamada S; Yamada K; Nagano A; Yamada S; Tsukushi S; Ishimura D; Matsumine A; Sudo A; Nishida Y
Anticancer Res; 2017 Jun; 37(6):3137-3141. PubMed ID: 28551655
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
[TBL] [Abstract][Full Text] [Related]
9. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications.
Chen W; Zhong S; Shan B; Zhou S; Wu X; Yang H; Ye S
J Ovarian Res; 2020 Aug; 13(1):89. PubMed ID: 32771026
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy.
Huang Y; Liu B; Sun Y; Zhang J; Yao Y; He A
Oncotarget; 2016 Oct; 7(40):65568-65576. PubMed ID: 27564105
[TBL] [Abstract][Full Text] [Related]
12. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
[TBL] [Abstract][Full Text] [Related]
13. Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.
Miwa S; Nishida H; Tanzawa Y; Takeuchi A; Hayashi K; Yamamoto N; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
Cancer; 2017 May; 123(9):1576-1584. PubMed ID: 28241093
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative plasma D-dimer level in patients with surgically resected clinical stage I non-small cell lung cancer: a retrospective cohort study.
Kaseda K; Asakura K; Kazama A; Ozawa Y
J Cardiothorac Surg; 2017 Nov; 12(1):102. PubMed ID: 29183325
[TBL] [Abstract][Full Text] [Related]
16. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
[TBL] [Abstract][Full Text] [Related]
17. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
